Nature Research Round Table: Defining and Maintaining Pluripotency & hPSC Line Registration and Banking - Panel Discussion
In this panel discussion led by Dr. Ludovic Vallier from the Wellcome Trust Sanger Institute and Dr. Joanne Mountford from the University of Glasgow, keynote speakers respond to questions from the forum and evaluate consensuses on topics raised in the previous talks.
This panel discussion was part of a Round Table series titled “Challenges in Ensuring hPSC Quality”, hosted in partnership with Nature Research. Global experts gathered at the Springer Nature headquarters in London, UK, to tackle some of the most pertinent issues impacting the use of human pluripotent stem cells (hPSCs), ranging from fundamental biology research to therapeutic applications. Explore the full series here.
This panel discussion was part of a Round Table series titled “Challenges in Ensuring hPSC Quality”, hosted in partnership with Nature Research. Global experts gathered at the Springer Nature headquarters in London, UK, to tackle some of the most pertinent issues impacting the use of human pluripotent stem cells (hPSCs), ranging from fundamental biology research to therapeutic applications. Explore the full series here.
Related Multimedia
-
Nature Research Round Table: Pluripotency Tests
Publish Date: November 01, 2019 -
Nature Research Round Table: Regulations Around Human Induced Pluripotent Stem Cell Registration
Publish Date: November 01, 2019 -
Nature Research Round Table: Standards for Pluripotent Stem Cell Banking
Publish Date: November 01, 2019
Explore Our Products
-
Defined, xeno-free matrix that supports the growth and differentiation of human pluripotent stem cells under serum-free, feeder-free conditions
-
cGMP, stabilized feeder-free maintenance medium for human ES and iPS cells